Citation Impact
Citing Papers
Systematic Review of Pretreatment Prostate-Specific Antigen Velocity and Doubling Time As Predictors for Prostate Cancer
2008
Cancer statistics, 2022
2022 Standout
Cancer statistics, 2023
2023 Standout
Pushing the Optical Imaging Limits of Cancer with Multi-Frequency-Band Raster-Scan Optoacoustic Mesoscopy (RSOM)
2015
Incorporation of tissue-based genomic biomarkers into localized prostate cancer clinics
2016
Predictive Value of Clinicopathological Markers for the Metachronous Bladder Cancer and Prognosis of Upper Tract Urothelial Carcinoma
2014
Cancer statistics, 2017
2017 Standout
Cancer statistics, 2020
2020 Standout
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Cancer statistics, 2019
2019 Standout
Cancer statistics, 2018
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Cancer Statistics, 2021
2021 Standout
Serum-Soluble B7x Is Elevated in Renal Cell Carcinoma Patients and Is Associated with Advanced Stage
2008 StandoutNobel
Expression of brain‐specific angiogenesis inhibitor 3 (BAI3) in normal brain and implications for BAI3 in ischemia‐induced brain angiogenesis and malignant glioma
2004
lincRNAs: Genomics, Evolution, and Mechanisms
2013 Standout
Systematic Review and Meta-analysis of Perioperative Outcomes and Complications After Robot-assisted Radical Prostatectomy
2012
Retrospective Evaluation of Risk Factors and Immunohistochemical Findings for Pre-Neoplastic and Neoplastic lesions of Upper Urinary Tract in Patients with Chronic Nephrolithiasis
2016
Combination of Adjuvant Hormonal and Radiation Therapy Significantly Prolongs Survival of Patients With pT2–4 pN+ Prostate Cancer: Results of a Matched Analysis
2011
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update
2015 Standout
Evaluation of hypoxia‐inducible factor 1α overexpression as a predictor of tumour recurrence and progression in superficial urothelial bladder carcinoma
2005
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 Standout
Bladder cancer in the elderly
2009
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
2017 Standout
Prognostic Factors in Upper Urinary Tract Urothelial Carcinomas: A Comprehensive Review of the Current Literature
2012
Systematic Review and Meta-analysis of Studies Reporting Potency Rates After Robot-assisted Radical Prostatectomy
2012
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
2008 Standout
Systematic Review and Meta-analysis of Studies Reporting Oncologic Outcome After Robot-assisted Radical Prostatectomy
2012
Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle‐invasive and non‐organ confined disease in patients with upper tract urothelial carcinoma
2011
European Guidelines on Upper Tract Urothelial Carcinomas: 2013 Update
2013
Influence of preoperative factors on the oncologic outcome for upper urinary tract urothelial carcinoma after radical nephroureterectomy
2014
Systematic Review and Meta-analysis of Studies Reporting Urinary Continence Recovery After Robot-assisted Radical Prostatectomy
2012
A Catalogue of Eukaryotic Transcription Factor Types, Their Evolutionary Origin, and Species Distribution
2011
The Human Transcription Factors
2018 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
The effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USA
2016
Robotic Partial Nephrectomy for Complex Renal Tumors: Surgical Technique
2007
Radical nephroureterectomy versus endoscopic procedures for the treatment of localised upper tract urothelial carcinoma: A meta-analysis and a systematic review of current evidence from comparative studies
2014
ICUD-EAU International Consultation on Bladder Cancer 2012: Radical Cystectomy and Bladder Preservation for Muscle-Invasive Urothelial Carcinoma of the Bladder
2012
Is there a prostate‐specific antigen upper limit for radical prostatectomy?
2011
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
2008 Standout
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
2013 Standout
Predictive factors of recurrence and survival of upper tract urothelial carcinomas
2011
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)
2016
Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review
2016
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
Outcome Predictors of Radical Prostatectomy in Patients With Prostate-Specific Antigen Greater Than 20 ng/ml: A European Multi-Institutional Study of 712 Patients
2010
Prevention of VTE in Nonorthopedic Surgical Patients
2012 Standout
Bladder cancer
2016 Standout
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
2012 Standout
Prevention of Venous Thromboembolism
2004 Standout
Survival Comparison Between Endoscopic and Surgical Management for Patients With Upper Tract Urothelial Cancer: A Matched Propensity Score Analysis Using Surveillance, Epidemiology and End Results-Medicare Data
2016
11C-Choline Positron Emission Tomography/Computerized Tomography for Preoperative Lymph-Node Staging in Intermediate-Risk and High-Risk Prostate Cancer: Comparison with Clinical Staging Nomograms
2008
The transferrin receptor part II: Targeted delivery of therapeutic agents into cancer cells
2006
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
2011 Standout
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error
2014
An Analysis of Radical Prostatectomy in Advanced Stage and High-Grade Prostate Cancer
2007
Low biopsy volume in ureteroscopy does not affect tumor biopsy grading in upper tract urothelial carcinoma
2012
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised Disease
2010
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
2008 Standout
Prevention of Venous Thromboembolism
2008 Standout
Expression and regulation of tumor suppressor gene maspin in human bladder cancer
2003
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
2015 Standout
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
2010 Standout
Neurovascular Structure-adjacent Frozen-section Examination (NeuroSAFE) Increases Nerve-sparing Frequency and Reduces Positive Surgical Margins in Open and Robot-assisted Laparoscopic Radical Prostatectomy: Experience After 11 069 Consecutive Patients
2012
A Contemporary Update on Pathology Reporting for Prostate Cancer: Biopsy and Radical Prostatectomy Specimens
2012
Lymphadenectomy at the Time of Nephroureterectomy for Upper Tract Urothelial Cancer
2011
Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression
2011
Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline
2018
Challenges in the treatment of bladder cancer
2006
Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review
2012
Intermediate-Term Potency, Continence, and Survival Outcomes of Radical Prostatectomy for Clinically High-Risk or Locally Advanced Prostate Cancer
2007
Cell Cycle Activation Linked to Neuronal Cell Death Initiated by DNA Damage
2004
Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study
2012
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
2009 StandoutNobel
Two Positive Nodes Represent a Significant Cut-off Value for Cancer Specific Survival in Patients with Node Positive Prostate Cancer. A New Proposal Based on a Two-Institution Experience on 703 Consecutive N+ Patients Treated with Radical Prostatectomy, Extended Pelvic Lymph Node Dissection and Adjuvant Therapy
2008
Pathways towards and away from Alzheimer's disease
2004 StandoutNature
Prognostic factors and selection for clinical studies of patients with kidney cancer
2007
Gene regulation by long non-coding RNAs and its biological functions
2020 Standout
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013
2013 Standout
Risk-adapted strategy for the kidney-sparing management of upper tract tumours
2015
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
2017 Standout
Optical Diagnostics for Upper Urinary Tract Urothelial Cancer: Technology, Thresholds, and Clinical Applications
2014
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Genome Regulation by Long Noncoding RNAs
2012 Standout
Upper Urinary Tract Carcinoma In Situ: Current Knowledge, Future Direction
2016
Evolving Principles of Surgical Management and Prognostic Factors for Outcome in Renal Cell Carcinoma
2006
Harm-to-Benefit of Three Decades of Prostate Cancer Screening in Black Men
2022
Emerging cancer incidence trends in Canada: The growing burden of young adult cancers
2020
Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study
2019
Cancer statistics in China, 2015
2016 Standout
Multicenter Phase II Study of Combined Neoadjuvant Docetaxel and Hormone Therapy Before Radical Prostatectomy for Patients With High Risk Localized Prostate Cancer
2008
Bladder Cancer
2020 Standout
Oncologic Outcomes Following Robot-Assisted Laparoscopic Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma
2015
Prostate Cancer Incidence 5 Years After US Preventive Services Task Force Recommendations Against Screening
2020
The cell-adhesion G protein-coupled receptor BAI3 is a high-affinity receptor for C1q-like proteins
2011 StandoutNobel
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
A Preoperative Prognostic Nomogram for Solid Enhancing Renal Tumors 7 cm or Less Amenable to Partial Nephrectomy
2007
Preoperative Hydronephrosis Grade Independently Predicts Worse Pathological Outcomes in Patients Undergoing Nephroureterectomy for Upper Tract Urothelial Carcinoma
2011
Incidence of Benign Lesions for Clinically Localized Renal Masses Smaller Than 7 cm in Radiological Diameter: Influence of Sex
2006
Intraoperative prognostic factors and atypical patterns of recurrence in patients with upper urinary tract urothelial carcinoma treated with laparoscopic radical nephroureterectomy
2016
Racial and Ethnic Variation in PSA Testing and Prostate Cancer Incidence Following the 2012 USPSTF Recommendation
2020
Cancer statistics, 2016
2016 Standout
Cancer statistics, 2015
2015 Standout
Renal Mass Biopsy—A Renaissance?
2007
Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities
2016 StandoutNobel
Bioorthogonal Labeling of Human Prostate Cancer Tissue Slice Cultures for Glycoproteomics
2017 StandoutNobel
Multiparametric prostate magnetic resonance imaging in the evaluation of prostate cancer
2015
Guideline for Management of the Clinical T1 Renal Mass
2009 Standout
Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
2008 Standout
Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations
2015
Photothermal Nanomaterials: A Powerful Light-to-Heat Converter
2023 Standout
Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of low-risk upper tract urothelial carcinoma
2016
Trends in United States Prostate Cancer Incidence Rates by Age and Stage, 1995–2012
2015
Works of Scott E. Eggener being referenced
Multi-institutional validation of the ability of preoperative hydronephrosis to predict advanced pathologic tumor stage in upper-tract urothelial carcinoma
2011
Urinary cytology has a poor performance for predicting invasive or high‐grade upper‐tract urothelial carcinoma
2011
Robotic Radical Prostatectomy in Overweight and Obese Patients: Oncological and Validated-Functional Outcomes
2008
Increasing incidence of testicular cancer in the United States and Europe between 1992 and 2009
2014
Genomic Predictors of Outcome in Prostate Cancer
2015
Focal Therapy in Prostate Cancer: International Multidisciplinary Consensus on Trial Design
2014
Secondary Therapy, Metastatic Progression, and Cancer-Specific Mortality in Men with Clinically High-Risk Prostate Cancer Treated with Radical Prostatectomy
2007
Increasing incidence of metastatic prostate cancer in the United States (2004–2013)
2016
Perioperative clinical thromboembolic events after radical or partial nephrectomy
2006
The Natural History of Noncastrate Metastatic Prostate Cancer after Radical Prostatectomy
2006
High-Grade Ureteroscopic Biopsy Is Associated with Advanced Pathology of Upper-Tract Urothelial Carcinoma Tumors at Definitive Surgical Resection
2011
Hazard of Prostate Cancer Specific Mortality After Radical Prostatectomy
2011
Preoperative Hydronephrosis, Ureteroscopic Biopsy Grade and Urinary Cytology Can Improve Prediction of Advanced Upper Tract Urothelial Carcinoma
2010
Predicting 15-Year Prostate Cancer Specific Mortality After Radical Prostatectomy
2011
POTENCY, CONTINENCE AND COMPLICATIONS IN 3,477 CONSECUTIVE RADICAL RETROPUBIC PROSTATECTOMIES
2004
Safety and Efficacy of Intravesical Bacillus Calmette-Guerin Instillations in Steroid Treated and Immunocompromised Patients
2006
PREDICTORS OF SUBSEQUENT PROSTATE CANCER IN MEN WITH A PROSTATE SPECIFIC ANTIGEN OF 2.6 TO 4.0 NG/ML AND AN INITIALLY NEGATIVE BIOPSY
2005
354 Focal therapy in prostate cancer – international multidisciplinary consensus on trial design
2014
National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen–Based Screening
2015
Radical Prostatectomy for Clinically Localized, High Risk Prostate Cancer: Critical Analysis of Risk Assessment Methods
2007
p53 AND MICROVESSEL DENSITY IN PRIMARY RESECTION SPECIMENS OF SUPERFICIAL BLADDER CANCER
2002
National trends in prostate cancer screening among older American men with limited 9‐year life expectancies: Evidence of an increased need for shared decision making
2014
Diffusion-Weighted and Dynamic Contrast-Enhanced MRI of Prostate Cancer: Correlation of Quantitative MR Parameters With Gleason Score and Tumor Angiogenesis
2011
Renal Tumors in Young Adults
2004
Timing Is Everything: Preclinical Evidence Supporting Simultaneous Rather Than Sequential Chemohormonal Therapy for Prostate Cancer
2005
Molecular Biomarkers in Localized Prostate Cancer: ASCO Guideline
2019
Association of Cysteine-Rich Secretory Protein 3 and β-Microseminoprotein with Outcome after Radical Prostatectomy
2007
Renal Cell Carcinoma Recurrence After Nephrectomy for Localized Disease: Predicting Survival From Time of Recurrence
2006
Temporary Renal Ischemia During Nephron Sparing Surgery is Associated With Short-Term but Not Long-Term Impairment in Renal Function
2006
The p53 Tumor Suppressor Gene and Nuclear Protein: Basic Science Review and Relevance in the Management of Bladder Cancer
2003
Contemporary Incidence and Outcomes of Prostate Cancer Lymph Node Metastases
2017
Length of Positive Surgical Margin After Radical Prostatectomy as a Predictor of Biochemical Recurrence
2009